Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

CHE Lu ¹ , YANG Ning ² ,  LI Yongjun. ¹

1.Department of Vascular Surgery， Peking Union Medical College Hospital， Peking Union Medical College， Chinese Academy of Medical Sciences， Beijing 100730， China;;
2.Department of Radiology， Peking Union Medical College Hospital， Peking Union Medical College， Chinese Academy of Medical Sciences， Beijing 100730， China;

Corresponding author：

LI Yongjun., Email: yongjun.li@foxmail.com

Keywords：

Resistant hypertension; Renal sympathetic denervation; Percutaneous radiofrequency catheter-based

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective 　To summary the effects and prospects of percutaneous radiofrequency catheter-based renal sympathetic denervation for resistant hypertension.
Methods 　Literatures which about the relationship between renal sympathetic nerves and hypertension， and the technical prospect and inadequacy of percutaneous radiofrequency catheter-based renal sympathetic denervation for resistant hypertension， were analyzed and reviewed.
Results 　Hypertension， which as a seriously public health problem， was the focus of clinical treatment currently. Renal sympathetic nerve was certified playing an important role in regulation of blood pressure， and percutaneous radiofrequency catheter-based renal sympathetic denervation had potential superiority in the treatment of resistant hypertension.
Conclusion 　Percutaneous radiofrequency catheter-based renal sympathetic denervation is an effective method for resistant hypertension.

Citation： CHE Lu,YANG Ning,LI Yongjun.. Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2013, 20(3): 340-343. doi: Copy

1.	Perkovic V， Huxley R， Wu Y， et al. The burden of blood pressure-related disease：a neglected priority for global health[J]. Hypertension， 2007， 50(6)： 991-997.
2.	(6757)： 403-408.
3.	Hajjar I， Kotchen TA. Trends in prevalence， awareness， treatment， and control of hypertension in the United States， 1988-2000[J]. JAMA， 2003， 290(2)： 199-206.
4.	Safian RD， Textor SC. Renal-artery stenosis[J]. N Engl J Med，.
5.	ASTRAL Investigators；Wheatley K， Ives N， et al. Revascularization versus medical therapy for renal-artery stenosis[J]. N Engl J Med， 2009， 361(20)： 1953-1962.
6.	Bax L， Woittiez AJ， Kouwenberg HJ， et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function： a randomized trial[J]. Ann Intern Med， 2009， 150(12)： 840-848.
7.	European Stroke Organisation；Tendera M， Aboyans V，et al. ESC guidelines on the diagnosis and treatment of peripheral arterydiseases： document covering atherosclerotic disease of extracranialcarotid and vertebral， mesenteric， renal， upper and lower extre-mity arteries： the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC)[J]. Eur Heart J， 2011， 32(22)： 2851-2906.
8.	Smithwick RH， Thompson JE. Splanchnicectomy for essential hypertension； results in 1 266 cases[J]. J Am Med Assoc， 1953， 152(16)： 1501-1504.
9.	Morrissey DM， Brookes VS， Cooke WT. Sympathectomy in thetreatment of hypertension； review of 122 cases[J]. Lancet， 1953，.
10.	Barajas L. Innervation of the renal cortex[J]. Fed Proc， 1978， 37(5)： 1192-1201.
11.	Bell-Reuss E， Trevino DL， Gottschalk CW. Effect of renal symp-athetic nerve stimulation on proximal water and sodium reabsorption[J]. J Clin Invest， 1976， 57(4)： 1104-1107.
12.	Kirchheim H， Ehmke H， Persson P. Sympathetic modulation of renal hemodynamics， renin release and sodium excretion[J]. Klin Wochenschr， 1989， 67(17)： 858-864.
13.	Zanchetti AS. Neural regulation of renin release： experimental evidence and clinical implications in arterial hypertension[J]. Circulation， 1977， 56(5)： 691-698.
14.	Barajas L， Liu L， Powers K. Anatomy of the renal innervation：intrarenal aspects and ganglia of origin[J]. Can J Physiol Pharmacol， 1992， 70(5)： 735-749.
15.	Grassi G， Seravalle G， Ghiadoni L， et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease[J]. Clin J Am Soc Nephrol， 2011， 6(11)： 2620-2627.
16.	Kopp UC. Endothelin in the control of renal sympathetic nerve activity[J]. Contrib Nephrol， 2011， 172： 107-119.
17.	Bruno RM， Ghiadoni L， Seravalle G， et al. Sympathetic regul-ation of vascular function in health and disease[J]. Front Physiol，.
18.	Rahmouni K. Leptin-induced sympathetic nerve activation： sign-aling mechanisms and cardiovascular consequences in obesity[J]. Curr Hypertens Rev， 2010， 6(2)： 104-209.
19.	Kumagai H， Oshima N， Matsuura T， et al. Importance of rostralventrolateral medulla neurons in determining efferent sympatheticnerve activity and blood pressure[J]. Hypertens Res， 2012， 35(2)： 132-141.
20.	Davisson RL， Zimmerman MC. AngiotensinⅡ， oxidant signaling， and hypertension： down to a T?[J]. Hypertension， 2010， 55(2)： 228-230.
21.	Dibona GF. Physiology in perspective： the wisdom of the body. Neural control of the kidney[J]. Am J Physiol Regul Integr Comp Physiol， 2005， 289(3)： R633-R641.
22.	Dibona GF， Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure[J]. Am J Physiol， 1991， 260(2 Pt 2)： R298-R305.
23.	Campese VM， Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure[J]. Hypertension， 1995， 25(4 Pt 2)： 878-882.
24.	Grimson KS. Total thoracic and partial to total lumbar sympath-ectomy and celiac ganglionectomy in the treatment of hypertension[J]. Ann Surg， 1941， 114(4)： 753-775.
25.	Doumas M， Faselis C， Papademetriou V. Renal sympathetic denervation and systemic hypertension[J]. Am J Cardiol， 2010，.
26.	Symplicity HTN-2 Investigators；Esler MD， Krum H， et al. Renalsympathetic denervation in patients with treatment-resistant hype-rtension (The Symplicity HTN-2 Trial)： a randomised controlled trial[J]. Lancet， 2010， 376(9756)： 1903-1909.
27.	Krum H， Schlaich M， Whitbourn R， et al. Catheter-based renal sympathetic denervation for resistant hypertension： a multicentre safety and proof-of-principle cohort study[J]. Lancet， 2009， 373(9671)： 1275-1281.
28.	Gan XB， Duan YC， Xiong XQ， et al. Inhibition of cardiac symp-athetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure[J]. PLoS One，.
29.	Mahfoud F， Lenski M， Böhm M. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?[J]. Future Cardiol， 2011， 7(5)： 591-594.
30.	Oparil S， Narkiewicz K， Kjeldsen S， et al. Renal nerve ablation：emerging role in therapeutics[J]. Blood Press， 2011， 20(5)： 253-255.
31.	Hansen JM， Abildgaard U， Fogh-Andersen N， et al. The trans-planted human kidney does not achieve functional reinnervation[J]. Clin Sci (Lond)， 1994， 87(1)： 13-20.
32.	Schlaich MP， Sobotka PA， Krum H， et al. Renal sympathetic-nerve ablation for uncontrolled hypertension[J]. N Engl J Med，.
33.	Rassaf T， Westenfeld R， Balzer J， et al. Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation[J]. Eur J Med Res， 2010， 15 Suppl 2： 83-87.
34.	Grisk O， Gröne HJ， Rose HJ， et al. Sympathetic reinnervation of rat kidney grafts[J]. Transplantation， 2001， 72(6)： 1153-1155.
35.	Stefanadis C. Renal denervation in resistant hypertension： radiofrequency ablation and chemical denervation[J]. Hellenic J Cardiol， 2011， 52(6)： 481-482.
36.	Mahfoud F， Himmel F， Ukena C， et al. Treatment strategies for resistant arterial hypertension[J]. Dtsch Arztebl Int， 2011， 108(43)： 725-731.
37.	Kandzari DE， Bhatt DL， Sobotka PA， et al. Catheter-based renal denervation for resistant hypertension： rationale and design of the SYMPLICITY HTN-3 Trial[J]. Clin Cardiol， 2012， 35(9)： 528-535.
38.	(4)： 570-576.
39.	， 344(6)： 431-442.
40.	， 361(9)： 932-934.
41.	， 6(10)： e25784.
42.	， 3： 284.

1. Perkovic V， Huxley R， Wu Y， et al. The burden of blood pressure-related disease：a neglected priority for global health[J]. Hypertension， 2007， 50(6)： 991-997.
2. (6757)： 403-408.
3. Hajjar I， Kotchen TA. Trends in prevalence， awareness， treatment， and control of hypertension in the United States， 1988-2000[J]. JAMA， 2003， 290(2)： 199-206.
4. Safian RD， Textor SC. Renal-artery stenosis[J]. N Engl J Med，.
5. ASTRAL Investigators；Wheatley K， Ives N， et al. Revascularization versus medical therapy for renal-artery stenosis[J]. N Engl J Med， 2009， 361(20)： 1953-1962.
6. Bax L， Woittiez AJ， Kouwenberg HJ， et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function： a randomized trial[J]. Ann Intern Med， 2009， 150(12)： 840-848.
7. European Stroke Organisation；Tendera M， Aboyans V，et al. ESC guidelines on the diagnosis and treatment of peripheral arterydiseases： document covering atherosclerotic disease of extracranialcarotid and vertebral， mesenteric， renal， upper and lower extre-mity arteries： the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC)[J]. Eur Heart J， 2011， 32(22)： 2851-2906.
8. Smithwick RH， Thompson JE. Splanchnicectomy for essential hypertension； results in 1 266 cases[J]. J Am Med Assoc， 1953， 152(16)： 1501-1504.
9. Morrissey DM， Brookes VS， Cooke WT. Sympathectomy in thetreatment of hypertension； review of 122 cases[J]. Lancet， 1953，.
10. Barajas L. Innervation of the renal cortex[J]. Fed Proc， 1978， 37(5)： 1192-1201.
11. Bell-Reuss E， Trevino DL， Gottschalk CW. Effect of renal symp-athetic nerve stimulation on proximal water and sodium reabsorption[J]. J Clin Invest， 1976， 57(4)： 1104-1107.
12. Kirchheim H， Ehmke H， Persson P. Sympathetic modulation of renal hemodynamics， renin release and sodium excretion[J]. Klin Wochenschr， 1989， 67(17)： 858-864.
13. Zanchetti AS. Neural regulation of renin release： experimental evidence and clinical implications in arterial hypertension[J]. Circulation， 1977， 56(5)： 691-698.
14. Barajas L， Liu L， Powers K. Anatomy of the renal innervation：intrarenal aspects and ganglia of origin[J]. Can J Physiol Pharmacol， 1992， 70(5)： 735-749.
15. Grassi G， Seravalle G， Ghiadoni L， et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease[J]. Clin J Am Soc Nephrol， 2011， 6(11)： 2620-2627.
16. Kopp UC. Endothelin in the control of renal sympathetic nerve activity[J]. Contrib Nephrol， 2011， 172： 107-119.
17. Bruno RM， Ghiadoni L， Seravalle G， et al. Sympathetic regul-ation of vascular function in health and disease[J]. Front Physiol，.
18. Rahmouni K. Leptin-induced sympathetic nerve activation： sign-aling mechanisms and cardiovascular consequences in obesity[J]. Curr Hypertens Rev， 2010， 6(2)： 104-209.
19. Kumagai H， Oshima N， Matsuura T， et al. Importance of rostralventrolateral medulla neurons in determining efferent sympatheticnerve activity and blood pressure[J]. Hypertens Res， 2012， 35(2)： 132-141.
20. Davisson RL， Zimmerman MC. AngiotensinⅡ， oxidant signaling， and hypertension： down to a T?[J]. Hypertension， 2010， 55(2)： 228-230.
21. Dibona GF. Physiology in perspective： the wisdom of the body. Neural control of the kidney[J]. Am J Physiol Regul Integr Comp Physiol， 2005， 289(3)： R633-R641.
22. Dibona GF， Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure[J]. Am J Physiol， 1991， 260(2 Pt 2)： R298-R305.
23. Campese VM， Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure[J]. Hypertension， 1995， 25(4 Pt 2)： 878-882.
24. Grimson KS. Total thoracic and partial to total lumbar sympath-ectomy and celiac ganglionectomy in the treatment of hypertension[J]. Ann Surg， 1941， 114(4)： 753-775.
25. Doumas M， Faselis C， Papademetriou V. Renal sympathetic denervation and systemic hypertension[J]. Am J Cardiol， 2010，.
26. Symplicity HTN-2 Investigators；Esler MD， Krum H， et al. Renalsympathetic denervation in patients with treatment-resistant hype-rtension (The Symplicity HTN-2 Trial)： a randomised controlled trial[J]. Lancet， 2010， 376(9756)： 1903-1909.
27. Krum H， Schlaich M， Whitbourn R， et al. Catheter-based renal sympathetic denervation for resistant hypertension： a multicentre safety and proof-of-principle cohort study[J]. Lancet， 2009， 373(9671)： 1275-1281.
28. Gan XB， Duan YC， Xiong XQ， et al. Inhibition of cardiac symp-athetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure[J]. PLoS One，.
29. Mahfoud F， Lenski M， Böhm M. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?[J]. Future Cardiol， 2011， 7(5)： 591-594.
30. Oparil S， Narkiewicz K， Kjeldsen S， et al. Renal nerve ablation：emerging role in therapeutics[J]. Blood Press， 2011， 20(5)： 253-255.
31. Hansen JM， Abildgaard U， Fogh-Andersen N， et al. The trans-planted human kidney does not achieve functional reinnervation[J]. Clin Sci (Lond)， 1994， 87(1)： 13-20.
32. Schlaich MP， Sobotka PA， Krum H， et al. Renal sympathetic-nerve ablation for uncontrolled hypertension[J]. N Engl J Med，.
33. Rassaf T， Westenfeld R， Balzer J， et al. Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation[J]. Eur J Med Res， 2010， 15 Suppl 2： 83-87.
34. Grisk O， Gröne HJ， Rose HJ， et al. Sympathetic reinnervation of rat kidney grafts[J]. Transplantation， 2001， 72(6)： 1153-1155.
35. Stefanadis C. Renal denervation in resistant hypertension： radiofrequency ablation and chemical denervation[J]. Hellenic J Cardiol， 2011， 52(6)： 481-482.
36. Mahfoud F， Himmel F， Ukena C， et al. Treatment strategies for resistant arterial hypertension[J]. Dtsch Arztebl Int， 2011， 108(43)： 725-731.
37. Kandzari DE， Bhatt DL， Sobotka PA， et al. Catheter-based renal denervation for resistant hypertension： rationale and design of the SYMPLICITY HTN-3 Trial[J]. Clin Cardiol， 2012， 35(9)： 528-535.
38. (4)： 570-576.
39. ， 344(6)： 431-442.
40. ， 361(9)： 932-934.
41. ， 6(10)： e25784.
42. ， 3： 284.

Previous Article
Chest Drainage Management after Pulmonary Lobectomy
Next Article
右侧开胸小切口清除多次心脏术后感染性心内膜炎赘生物一例

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content